ID   RIBB_METJA              Reviewed;         227 AA.
AC   Q60364;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   24-JUN-2015, entry version 99.
DE   RecName: Full=3,4-dihydroxy-2-butanone 4-phosphate synthase;
DE            Short=DHBP synthase;
DE            EC=4.1.99.12;
GN   Name=ribB; OrderedLocusNames=MJ0055;
OS   Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 /
OS   JCM 10045 / NBRC 100440) (Methanococcus jannaschii).
OC   Archaea; Euryarchaeota; Methanococci; Methanococcales;
OC   Methanocaldococcaceae; Methanocaldococcus.
OX   NCBI_TaxID=243232;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440;
RX   PubMed=8688087; DOI=10.1126/science.273.5278.1058;
RA   Bult C.J., White O., Olsen G.J., Zhou L., Fleischmann R.D.,
RA   Sutton G.G., Blake J.A., FitzGerald L.M., Clayton R.A., Gocayne J.D.,
RA   Kerlavage A.R., Dougherty B.A., Tomb J.-F., Adams M.D., Reich C.I.,
RA   Overbeek R., Kirkness E.F., Weinstock K.G., Merrick J.M., Glodek A.,
RA   Scott J.L., Geoghagen N.S.M., Weidman J.F., Fuhrmann J.L., Nguyen D.,
RA   Utterback T.R., Kelley J.M., Peterson J.D., Sadow P.W., Hanna M.C.,
RA   Cotton M.D., Roberts K.M., Hurst M.A., Kaine B.P., Borodovsky M.,
RA   Klenk H.-P., Fraser C.M., Smith H.O., Woese C.R., Venter J.C.;
RT   "Complete genome sequence of the methanogenic archaeon, Methanococcus
RT   jannaschii.";
RL   Science 273:1058-1073(1996).
RN   [2]
RP   PROTEIN SEQUENCE OF 1-15, FUNCTION, MASS SPECTROMETRY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, COFACTOR, AND MUTAGENESIS OF
RP   ASP-21; ARG-25; GLU-26; GLU-28; ASP-30; CYS-55; THR-112; ARG-119;
RP   ARG-161; HIS-164; THR-165; GLU-166 AND GLU-185.
RX   PubMed=12200440; DOI=10.1074/jbc.M206863200;
RA   Fischer M., Roemisch W., Schiffmann S., Kelly M., Oschkinat H.,
RA   Steinbacher S., Huber R., Eisenreich W., Richter G., Bacher A.;
RT   "Biosynthesis of riboflavin in archaea studies on the mechanism of
RT   3,4-dihydroxy-2-butanone-4-phosphate synthase of Methanococcus
RT   jannaschii.";
RL   J. Biol. Chem. 277:41410-41416(2002).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF MUTANT SER-147 IN COMPLEX
RP   WITH DIVALENT METAL CATIONS AND SUBSTRATE, AND SUBUNIT.
RX   PubMed=12904291; DOI=10.1074/jbc.M307301200;
RA   Steinbacher S., Schiffmann S., Richter G., Huber R., Bacher A.,
RA   Fischer M.;
RT   "Structure of 3,4-dihydroxy-2-butanone 4-phosphate synthase from
RT   Methanococcus jannaschii in complex with divalent metal ions and the
RT   substrate ribulose 5-phosphate: implications for the catalytic
RT   mechanism.";
RL   J. Biol. Chem. 278:42256-42265(2003).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF MUTANT SER-147 IN COMPLEX
RP   WITH DIVALENT METAL CATIONS AND SUBSTRATE, AND SUBUNIT.
RX   PubMed=15213409; DOI=10.1107/S0907444904009862;
RA   Steinbacher S., Schiffmann S., Bacher A., Fischer M.;
RT   "Metal sites in 3,4-dihydroxy-2-butanone 4-phosphate synthase from
RT   Methanococcus jannaschii in complex with the substrate ribulose 5-
RT   phosphate.";
RL   Acta Crystallogr. D 60:1338-1340(2004).
CC   -!- FUNCTION: Catalyzes the conversion of D-ribulose 5-phosphate to
CC       formate and 3,4-dihydroxy-2-butanone 4-phosphate.
CC       {ECO:0000269|PubMed:12200440}.
CC   -!- CATALYTIC ACTIVITY: D-ribulose 5-phosphate = formate + L-3,4-
CC       dihydroxybutan-2-one 4-phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:12200440};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:12200440};
CC       Note=Binds 2 divalent metal cations per subunit. Magnesium or
CC       manganese. {ECO:0000269|PubMed:12200440};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=140 uM for ribulose-5-phosphate
CC         {ECO:0000269|PubMed:12200440};
CC         Vmax=148 nmol/min/mg enzyme {ECO:0000269|PubMed:12200440};
CC   -!- PATHWAY: Cofactor biosynthesis; riboflavin biosynthesis; 2-
CC       hydroxy-3-oxobutyl phosphate from D-ribulose 5-phosphate: step
CC       1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:12200440,
CC       ECO:0000269|PubMed:12904291, ECO:0000269|PubMed:15213409}.
CC   -!- MASS SPECTROMETRY: Mass=25799; Method=Electrospray; Range=1-227;
CC       Evidence={ECO:0000269|PubMed:12200440};
CC   -!- SIMILARITY: Belongs to the DHBP synthase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L77117; AAB98035.1; -; Genomic_DNA.
DR   PIR; G64306; G64306.
DR   RefSeq; NP_247019.1; NC_000909.1.
DR   RefSeq; WP_010869547.1; NC_000909.1.
DR   PDB; 1PVW; X-ray; 2.45 A; A/B/C=1-227.
DR   PDB; 1PVY; X-ray; 1.70 A; A/B=1-227.
DR   PDB; 1SNN; X-ray; 1.55 A; A/B=1-227.
DR   PDBsum; 1PVW; -.
DR   PDBsum; 1PVY; -.
DR   PDBsum; 1SNN; -.
DR   ProteinModelPortal; Q60364; -.
DR   SMR; Q60364; 2-220.
DR   STRING; 243232.MJ_0055; -.
DR   EnsemblBacteria; AAB98035; AAB98035; MJ_0055.
DR   GeneID; 1450894; -.
DR   KEGG; mja:MJ_0055; -.
DR   eggNOG; COG0108; -.
DR   InParanoid; Q60364; -.
DR   KO; K02858; -.
DR   OMA; QMAKLIR; -.
DR   PhylomeDB; Q60364; -.
DR   BioCyc; MetaCyc:MONOMER-14603; -.
DR   BRENDA; 4.1.99.12; 3260.
DR   UniPathway; UPA00275; UER00399.
DR   EvolutionaryTrace; Q60364; -.
DR   Proteomes; UP000000805; Chromosome.
DR   GO; GO:0008686; F:3,4-dihydroxy-2-butanone-4-phosphate synthase activity; IEA:UniProtKB-HAMAP.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0030145; F:manganese ion binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0009231; P:riboflavin biosynthetic process; IEA:UniProtKB-HAMAP.
DR   Gene3D; 3.90.870.10; -; 1.
DR   HAMAP; MF_00180; RibB; 1.
DR   InterPro; IPR017945; DHBP_synth_RibB-like_a/b_dom.
DR   InterPro; IPR000422; DHBP_synthase_RibB.
DR   Pfam; PF00926; DHBP_synthase; 1.
DR   SUPFAM; SSF55821; SSF55821; 1.
DR   TIGRFAMs; TIGR00506; ribB; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing; Lyase;
KW   Magnesium; Manganese; Metal-binding; Reference proteome;
KW   Riboflavin biosynthesis.
FT   CHAIN         1    227       3,4-dihydroxy-2-butanone 4-phosphate
FT                                synthase.
FT                                /FTId=PRO_0000151825.
FT   REGION       25     26       Substrate binding.
FT   REGION      161    165       Substrate binding.
FT   METAL        26     26       Magnesium or manganese 1.
FT   METAL        26     26       Magnesium or manganese 2.
FT   METAL       164    164       Magnesium or manganese 2.
FT   BINDING      30     30       Substrate. {ECO:0000269|PubMed:12904291,
FT                                ECO:0000269|PubMed:15213409}.
FT   BINDING     185    185       Substrate. {ECO:0000269|PubMed:12904291,
FT                                ECO:0000269|PubMed:15213409}.
FT   SITE        147    147       Essential for catalytic activity.
FT   SITE        185    185       Essential for catalytic activity.
FT   MUTAGEN      21     21       D->E,N: Loss of activity.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN      21     21       D->S: Reduces activity 70-fold.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN      25     25       R->E,K: Reduces activity 50-fold.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN      26     26       E->D,Q,S: Loss of activity.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN      28     28       E->D,S: Loss of activity.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN      28     28       E->Q: Reduces activity 23-fold.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN      30     30       D->E,N: Loss of activity.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN      30     30       D->S: Reduces activity 30-fold.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN      55     55       C->G: Reduces activity 70-fold. Increases
FT                                Km for ribulose-5-phosphate 7-fold.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN      55     55       C->S: Reduces activity 30-fold.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN     112    112       T->A: Reduces activity 50-fold. Increases
FT                                Km for ribulose-5-phosphate 10-fold.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN     119    119       R->S: Reduces activity 8-fold. Increases
FT                                Km for ribulose-5-phosphate 8-fold.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN     147    147       H->S: Reduces activity 10-fold.
FT   MUTAGEN     161    161       R->S: Reduces activity 10-fold. Increases
FT                                Km for ribulose-5-phosphate 7-fold.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN     164    164       H->N,S: Loss of activity.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN     165    165       T->A: Reduces activity by 2-fold.
FT                                Increases Km for ribulose-5-phosphate 8-
FT                                fold. {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN     165    165       T->S: Reduces activity by 3-fold.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN     166    166       E->S: Increases Km for ribulose-5-
FT                                phosphate 8-fold.
FT                                {ECO:0000269|PubMed:12200440}.
FT   MUTAGEN     185    185       E->D,Q,S: Loss of activity.
FT                                {ECO:0000269|PubMed:12200440}.
FT   HELIX         3     12       {ECO:0000244|PDB:1SNN}.
FT   STRAND       17     20       {ECO:0000244|PDB:1SNN}.
FT   TURN         23     26       {ECO:0000244|PDB:1SNN}.
FT   STRAND       29     34       {ECO:0000244|PDB:1SNN}.
FT   HELIX        35     37       {ECO:0000244|PDB:1SNN}.
FT   HELIX        40     49       {ECO:0000244|PDB:1SNN}.
FT   STRAND       51     58       {ECO:0000244|PDB:1SNN}.
FT   HELIX        60     66       {ECO:0000244|PDB:1SNN}.
FT   HELIX        71     78       {ECO:0000244|PDB:1SNN}.
FT   TURN         79     81       {ECO:0000244|PDB:1SNN}.
FT   HELIX        83     87       {ECO:0000244|PDB:1SNN}.
FT   STRAND       96     98       {ECO:0000244|PDB:1SNN}.
FT   STRAND      101    107       {ECO:0000244|PDB:1SNN}.
FT   STRAND      111    113       {ECO:0000244|PDB:1SNN}.
FT   HELIX       116    131       {ECO:0000244|PDB:1SNN}.
FT   HELIX       135    137       {ECO:0000244|PDB:1SNN}.
FT   HELIX       138    141       {ECO:0000244|PDB:1SNN}.
FT   STRAND      142    152       {ECO:0000244|PDB:1SNN}.
FT   HELIX       157    159       {ECO:0000244|PDB:1SNN}.
FT   HELIX       164    174       {ECO:0000244|PDB:1SNN}.
FT   STRAND      179    187       {ECO:0000244|PDB:1SNN}.
FT   STRAND      191    193       {ECO:0000244|PDB:1SNN}.
FT   HELIX       196    206       {ECO:0000244|PDB:1SNN}.
FT   STRAND      210    212       {ECO:0000244|PDB:1SNN}.
FT   HELIX       213    219       {ECO:0000244|PDB:1SNN}.
SQ   SEQUENCE   227 AA;  25797 MW;  0718EE5B4247995D CRC64;
     MNNVEKAIEA LKKGEIILVY DSDEREGETD MVVASQFITP EHIRIMRKDA GGLICTALHP
     DICNKLGIPF MVDILEFASQ KFKVLRELYP NDIPYDEKSS FSITINHRKT FTGITDNDRA
     FTIKKLAELV KEGRFNDFGK EFRSPGHVTL LRAAEGLVKN RQGHTEMTVA LAELANLVPI
     TTICEMMGDD GNAMSKNETK RYAEKHNLIY LSGEEIINYY LDKYLKD
//
